|
Volumn 345, Issue 8950, 1995, Pages 625-630
|
Tacrine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLCHOLINESTERASE;
BETHANECHOL;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
CHOLINERGIC RECEPTOR STIMULATING AGENT;
CHOLINESTERASE INHIBITOR;
CIMETIDINE;
LIVER ENZYME;
MIVACURIUM;
NEOSTIGMINE;
NEUROMUSCULAR BLOCKING AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
PHOSPHATIDYLCHOLINE;
SUXAMETHONIUM;
TACRINE;
THEOPHYLLINE;
ALZHEIMER DISEASE;
ANOREXIA;
ARTICLE;
ATAXIA;
CHOLINERGIC ACTIVITY;
CLINICAL TRIAL;
COGNITIVE DEFECT;
CONSTIPATION;
DIARRHEA;
DOUBLE BLIND PROCEDURE;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG COST;
DRUG DOSE;
DRUG EFFICACY;
DRUG ELIMINATION;
DRUG HALF LIFE;
DRUG MECHANISM;
DRUG METABOLISM;
DRUG STRUCTURE;
DYSPEPSIA;
FLATULENCE;
HUMAN;
LIVER TOXICITY;
META ANALYSIS;
MYALGIA;
NAUSEA;
PRIORITY JOURNAL;
RASH;
RHINITIS;
SMOKING;
THEOPHYLLINE BLOOD LEVEL;
TOBACCO;
TREMOR;
VOMITING;
|
EID: 0028922858
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(95)90526-X Document Type: Article |
Times cited : (211)
|
References (37)
|